
Mark Ayzenberg, MD, FAAOS
Shoulder osteoarthritis (OA), Rotator cuff tears (RCT) and Adhesive capsulitis (frozen shoulder) pose significant challenges, often causing pain, stiffness, and functional limitations. While conventional treatments sometimes offer relief, Platelet-Rich Plasma (PRP) therapy has emerged as a promising avenue for managing these shoulder conditions. In this blog post, we explore recent research studies that illuminate the effectiveness of PRP for these conditions.
Recent research studies provide compelling evidence supporting the efficacy of Platelet-Rich Plasma (PRP) therapy for shoulder osteoarthritis (OA), rotator cuff tendinopathy and partial tearing as well as adhesive capsulitis (frozen shoulder). As PRP continues to gain momentum as a therapeutic option for shoulder OA, ongoing research endeavors will further elucidate its optimal use, refine treatment protocols, and optimize clinical outcomes, offering hope for improved quality of life for patients suffering with shoulder pain.